Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CollPlant Biotechnologies (CLGN) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for CollPlant Biotechnologies (CLGN) over the last 8 years, with Q3 2025 value amounting to -$1000.0.

  • CollPlant Biotechnologies' Cash from Investing Activities rose 9928.57% to -$1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$70000.0, marking a year-over-year increase of 9179.37%. This contributed to the annual value of -$539000.0 for FY2024, which is 5337.37% up from last year.
  • Latest data reveals that CollPlant Biotechnologies reported Cash from Investing Activities of -$1000.0 as of Q3 2025, which was up 9928.57% from -$3000.0 recorded in Q2 2025.
  • CollPlant Biotechnologies' Cash from Investing Activities' 5-year high stood at $29.9 million during Q1 2022, with a 5-year trough of -$31.6 million in Q4 2021.
  • For the 5-year period, CollPlant Biotechnologies' Cash from Investing Activities averaged around -$1.3 million, with its median value being -$243000.0 (2023).
  • Data for CollPlant Biotechnologies' Cash from Investing Activities shows a peak YoY increase of 719469.7% (in 2021) and a maximum YoY decrease of 3540470.59% (in 2021) over the last 5 years.
  • CollPlant Biotechnologies' Cash from Investing Activities (Quarter) stood at -$31.6 million in 2021, then surged by 99.04% to -$304000.0 in 2022, then dropped by 22.37% to -$372000.0 in 2023, then soared by 84.41% to -$58000.0 in 2024, then surged by 98.28% to -$1000.0 in 2025.
  • Its last three reported values are -$1000.0 in Q3 2025, -$3000.0 for Q2 2025, and -$8000.0 during Q1 2025.